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Background
From the 1940s up to the 1990s, chloroquine (CQ) was
the main malaria therapy worldwide. Following the CQ
resistance burden in Africa, most African countries have
discontinued CQ during the past 2 decades, and now pro-
mote artemisinin-based combination therapy (ACT), as
the first-line treatment for uncomplicated malaria. The
policy changed in West Africa during the last decade
(2002 in Cameroon; 2003 in Senegal and Cote d’l voire;
2004 in Mali). The aim of this study is to describe the evo-
lution of CQ resistance in West Africa, through travellers
returning from this region.
Methods
The study was conducted by the Malaria National Refer-
ence Centre, France. The database collated in vitro
response of reference and clinical isolates for CQ and the
pfcrtK76 molecular marker for CQ susceptible Pf malaria
from travellers returning from Cameroon, Senegal, Cote
d’lvoire and Mali. As a proxy of drug pressure, CQ intake
for children under five years of age with fever was
extracted from the Demographic Health Surveys (DHS)
and Multiple Indicator Cluster Surveys (MICS) for the
study period [1,2]. Logistic regression models were used to
detect trends in the susceptible isolates proportions.
Results
From 2000 to 2011, around 700 isolates were genotyped
for each country. The frequency of the pfcrt76 wild-type
significantly increased for Cameroon (CM) (from 10% to
41%, Slope=0.09, p<10-3), Cote d’lvoire (CI) (from 37%
to 63%, Slope = 0.14, p<10-3), and Senegal (SN) (from
22% to 53%, Slope=0.17, p<10-3). The geometric mean of
the 50% growth inhibition (IC50) of CQ decreased from
181 nM (95% confidence interval, 87-374) (25% CQ sen-
sitive) to 51 nM (37-71) (63% CQ sensitive) in CM, from
75nM (43-130) (41% CQ sensitive) to 29nM (22-39) (84%
CQ sensitive) in CI and from 86nM (51-145) (41% CQ
sensitive) to 39nM (26-60) (75% CQ sensitive) in SN.
Analyses performed from 2004 to 2011, when most of
West African countries have officially discontinued CQ,
confirmed previous results and also show a significant
increase of the prevalence of pfcrt76 wild-type genotype
for Mali (ML) (Slope = 0.07, p=0.02). Meanwhile, CQ use
among children with fever significantly decreased during
this period.
Conclusions
An increase of CQ susceptibility following official withdra-
wal is observed in travellers returning from Cameroon,
Cote d’lvoire, Mali and Senegal. The length of time
between policy changes and their subsequent implementa-
tion, as well as the cross resistance between antimalarial
drugs, may affect the time for a significant recovery of CQ
sensitivity. This information should be compared to coun-
try level CQ efficacy data.
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